| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |